Crinetics Pharmaceuticals, Inc. CRNX
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Jonathan Wolleben | JMP Securities | 45.91 $ | 143 $ | 97.09 % | 26/09/2025 |
| Richard Law | Goldman Sachs | 31.99 $ | 36 $ | 4.01 % | 10/07/2025 |
| Alex Thompson | Stifel Nicolaus | 35.94 $ | 60 $ | 24.06 % | 24/03/2025 |
| Douglas Tsao | H.C. Wainwright | 50.74 $ | 69 $ | 18.26 % | 09/08/2024 |
| Leland Gershell | Oppenheimer | 46.28 $ | 74 $ | 27.72 % | 04/06/2024 |
| Brian Skorney | Robert W. Baird | 49.13 $ | 62 $ | 12.87 % | 23/05/2024 |
| Jeffrey Hung | Morgan Stanley | 50.54 $ | 70 $ | 19.46 % | 22/05/2024 |
| Yasmeen Rahimi | Piper Sandler | 47.47 $ | 97 $ | 49.53 % | 07/05/2024 |
| Jonathan Wolleben | JMP Securities | 45.49 $ | 80 $ | 34.51 % | 20/03/2024 |
| Leland Gershell | Oppenheimer | 40.5 $ | 54 $ | 13.50 % | 13/03/2024 |
| Leland Gershell | Oppenheimer | 17.43 $ | 40 $ | 22.57 % | 31/08/2023 |